Federal contract award
75N95A25F00003
CUSTOM OLIGOS USED TO PERFORM CRITICAL EXPERIMENTS FOR THE LAB FOR ONGOING RESEARCH THAT STARTED PRIOR TO JANUARY 20, 2025 AS NOT TO LOSE INVESTMENT IN RESEARCH STUDIES FOCUS ON DISCOVERING THE FUNCTIONS AND INTERRELATIONSHIPS AMONG PROTEINS MUTATED
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NINDS |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | 75N98024A00124 |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $7.5K |
| Current contract value | $7.5K |
| Potential contract value / ceiling | $7.5K |
| Start date | Dec 19, 2024 |
| Current end date | Dec 18, 2025 |
| Potential end date | Dec 18, 2025 |
| Latest award activity | May 7, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 7, 2025 | 0 | $7.5K | CUSTOM OLIGOS USED TO PERFORM CRITICAL EXPERIMENTS FOR THE LAB FOR ONGOING RESEARCH THAT STARTED PRIOR TO JANUARY 20, 2025 AS NOT TO LOSE INVESTMENT IN RESEARCH STUDIES FOCUS ON DISCOVERING THE FUNCTIONS AND INTERRELATIONSHIPS AMONG PROTEINS MUTATED |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.